Results 1-164 of 164 (Search time: 0.002 seconds).

Issue DateTitleAuthor(s)SourceWOSFulltext/Archive link
12023Investigation into increasing wave energy density by a crescent shoalBo-Jun Wang; Chi-Yu Li ; Ruey Syan Shih ; Wen-Kai Weng 
22023Experimental Study of energy dissipation effects of oscillating water column structuresRuey-Syan Shih ; Chi-Yu Li ; Wen-Kai Weng ; Yung-Ching Liu; Ta-Wei Lin
32022以 PIV 技術探討浮式翼板結構物引起的渦流能量特性之研究吳佳承; 石瑞祥 ; 李基毓 ; 翁文凱 ; 謝仁瑋第44屆海洋工程研討會
42022Relative Energy Variation Characteristics Considering Interaction between Waves and Vegetation StructureShih, Ruey-Syan ; Li, Chi-Yu ; Weng, Wen-Kai ; Lin, Chih-HungWATER-SUI0
52021以Telemac-Mascaret數值模式模擬南澳漁港漂砂問題改善研究林于凱; 李基毓 ; 石瑞祥 ; 翁文凱 ; 張友力第 43 屆海洋工程研討會論文集
62021以PIV技術探討浮式翼板結構物引起的渦流能量特性之研究程皓; 石瑞祥 ; 翁文凱 ; 李基毓 ; 林志鴻; 吳佳承第 43 屆海洋工程研討會論文集
72021Analysis of vortex formation and energy dissipation during interaction of solitary-like waves with submerged breakwaters based on particle image velocimetryLi, Chi-Yu ; Shih, Ruey-Syan ; Weng, Wen-Kai ; Liao, Ting-WeiAPPLIED OCEAN RESEARCH5
82020Study of a deep draft vessel to enhance onsite installation capability of a jack up type unit operating in the wind farm zone offshore of the Taichung Harbor TaiwanY.Z. Kehr; G.A. Chang; G.J. Huang; Wen-Kai Weng OCEAN ENG1
92020以PIV技術探討類孤立波通過沒水結構物之渦流形成與能量衰減特性研究石瑞祥 ; 李基毓 ; 翁文凱 ; 廖庭葳
102020波浪通過新月型淺灘引起之非線性變化翁文凱 ; 王濬祐; 石瑞祥 ; 李基毓 第28屆海洋工程研討會
112020波浪與結構物互制場域中考量正向流和反向流對波能衰減評估結果之影響研究石瑞祥 ; 李基毓 ; 翁文凱 ; 吳佳瀛第28屆海洋工程研討會
122020Visualization Investigation of Energy Dissipation Induced by Eddy Currents for a Solitary-Like Wave Passing over Submerged Breakwater SetsLi, Chi-Yu ; Shih, Ruey-Syan ; Weng, Wen-Kai J MAR SCI ENG3
132020Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trialFrank, M. J.; Khodadoust, M. S.; Czerwinski, D. K.; Haabeth, O. A. W.; Chu, M. P.; Miklos, D. B.; Advani, R. H.; Alizadeh, A. A.; Gupta, N. K.; Maeda, L. S.; Reddy, S. A.; Laport, G. G.; Meyer, E. H.; Negrin, R. S.; Rezvani, A. R.; Wen-Kai Weng ; Sheehan, K.; Faham, M.; Okada, A.; Moore, A. H.; Phillips, D. L.; Wapnir, I. L.; Brody, J. D.; Levy, R.Journal of Experimental Medicine
142020Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphomaWen-Kai Weng ; Arai, S.; Rezvani, A.; Johnston, L.; Lowsky, R.; Miklos, D.; Shizuru, J.; Muffly, L.; Meyer, E.; Negrin, R. S.; Wang, E.; Almazan, T.; Million, L.; Khodadoust, M.; Li, S. F.; Hoppe, R. T.; Kim, Y. H.Blood Advances
152020Wave-Structure-Current interactions over smooth and rough breakwatersRuey-Syan Shih ; Chi-Yu Li ; Wen-Kai Weng Ships and Offshore Structures0
162020以PIV技術探討沒水結構物之渦流形成與能量衰減特性研究廖庭葳; 石瑞祥 ; 李基毓 ; 翁文凱 109年度海工研討會
172020波浪通過新月型淺灘引起之波浪非線性變化初探王濬祐; 李基毓 ; 石瑞祥 ; 翁文凱 
182020Long-Term Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in a Multicenter Expanded Access Program StudyProckop, S. E.; Reshef, R.; Tsai, D. E.; Bunin, N.; Abu-Arja, R.; Mahadeo, K. M.; Wen-Kai Weng ; van Besien, K.; Loeb, D.; Nasta, S. D.; Nemecek, E. R.; Hiremath, M.; Yue, S.; Sun, Y.; Navarro, W. H.; Nikiforow, S.Biology of Blood and Marrow Transplantation
192020Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Significant Increase in Survival in the Post-Targeted Immunotherapy EraMuffly, L.; Arai, S.; Johnston, L.; Lowsky, R.; Meyer, E. H.; Miklos, D. B.; Negrin, R. S.; Rezvani, A.; Shiraz, P.; Shizuru, J. A.; Sidana, S.; Wen-Kai Weng ; Cunanan, K.Biology of Blood and Marrow Transplantation
202020Investigation of Ocean-Wave-Focusing Characteristics Induced by a Submerged Crescent-Shaped Plate for Long-Crested WavesLi, Chi-Yu ; Shih, Ruey-Syan ; Weng, Wen-Kai WATER-SUI2
212019波浪作用於階梯型沒水潛堤之消能特性暨二維波動流場變化之研究石瑞祥 ; 翁文凱 ; 李基毓 ; 林佳欣; 劉俊秀
222019以緩坡方程式探討不同幾何參數新月型淺灘之聚波現象翁文凱 ; 吳聲陽; 石瑞祥; 李基毓 第 41 屆海洋工程研討會論文集
232019Characteristics of wave attenuation due to roughness of stepped obstaclesRuey-Syan Shih ; Wen-Kai Weng ; Chi-Yu Li Ships and Offshore Structures7
242019Enhancing Wave Energy Harvesting with a Submerged Crescent-Shaped PlateLi, Chi-Yu ; Weng, Wen-Kai ; Shih, Ruey-Syan ; Yang, Chia-Kai; Lo, Jheng-SyuanJOURNAL OF COASTAL RESEARCH0
252019Enhancing Wave Energy Harvesting with a Submerged Crescent-Shaped PlateChi-Yu Li ; Wen-Kai Weng ; Ruey-Syan Shih ; Chia-Kai Yang; Jheng-Syuan LoJournal of Coastal Research0
262019Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohortSpinner, M. A.; Kennedy, V. E.; Tamaresis, J. S.; Lavori, P. W.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Hoppe, R. T.; Strober, S.; Lowsky, R.Blood Advances
272019Volumetric Modulated Arc Therapy and 3-Dimensional Printed Bolus in the Treatment of Refractory Primary Cutaneous Gamma Delta Lymphoma of the Bilateral LegsObeid, J. P.; Gutkin, P. M.; Lewis, J.; Skinner, L.; Wang, E. B.; Khodadoust, M. S.; Kim, Y. H.; Wen-Kai Weng ; Hoppe, R. T.; Hiniker, S. M.Practical Radiation Oncology
282019Investigation on the Wave Attenuation and Reflection Induced by a Submerged Barrier in Presence of Small Forward and Reversed CurrentsRuey-Syan Shih ; Wen-Kai Weng ; Chi-Yu Li ; Chia-Ying Wu; Ying-Chi WangThe 29th International Ocean and Polar Engineering Conference
292019RETRACTION: Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer (Retraction of Vol 122, Pg 1066, 2012)Kohrt, H. E.; Houot, R.; Weiskopf, K.; Goldstein, M. J.; Scheeren, F.; Czerwinski, D.; Colevas, A. D.; Wen-Kai Weng ; Clarke, M. F.; Carlson, R. W.; Stockdale, F. E.; Mollick, J. A.; Chen, L. P.; Levy, R.Journal of Clinical Investigation
302019RETRACTION: Targeting CD137 enhances the efficacy of cetuximab (Retraction of Vol 124, Pg 2668, 2014)Kohrt, H. E.; Colevas, A. D.; Houot, R.; Weiskopf, K.; Goldstein, M. J.; Lund, P.; Mueller, A.; Sagiv-Barfi, I.; Marabelle, A.; Lira, R.; Troutner, E.; Richards, L.; Rajapaska, A.; Hebb, J.; Chester, C.; Waller, E.; Ostashko, A.; Wen-Kai Weng ; Chen, L. P.; Czerwinski, D.; Fu, Y. X.; Sunwoo, J.; Levy, R.Journal of Clinical Investigation
312019Investigation on the wave attenuation physical quantities of stepped embankments considering forward and reversed flow fieldRuey-Syan Shih ; Wen-Kai Weng ; Chi-Yu Li ; Chia-Ying Wu; Ying-Chi Wang
322019Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipientsMeyer, E. H.; Laport, G.; Xie, B. J.; MacDonald, K.; Heydari, K.; Sahaf, B.; Tang, S. W.; Baker, J.; Armstrong, R.; Tate, K.; Tadisco, C.; Arai, S.; Johnston, L.; Lowsky, R.; Muffly, L.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Sheehan, K.; Miklos, D.; Negrin, R. S.Jci Insight
332019Correlation of circulating EBV-targeted cytotoxic T lymphocyte precursors (EBV-CTLp) and clinical response following tabelecleucel (tab-cel) infusion in patients with EBV-driven diseaseAftab, B. T.; Munson, D.; Rasor, K.; Foubert, P.; Tsai, D. E.; Wen-Kai Weng ; Ghobadi, A.; Van Besien, K.; Sun, Y.; Hiremath, M.; Navarro, W. H.; Prockop, S.Journal of Clinical Oncology
342018Elevated Axicabtagene Ciloleucel (CAR-19) Expansion By Immunophenotyping Is Associated with Toxicity in Diffuse Large B-Cell LymphomaSpiegel, J. Y.; Sahaf, B.; Hossain, N.; Frank, M. J.; Claire, G.; Abramian, M.; Latchford, T.; Villa, B.; Cancilla, J.; Oak, J.; Natkunam, Y.; Long, S. R.; Arai, S.; Johnston, L. J.; Lowsky, R.; Meyer, E. H.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Kong, K. A.; Mackall, C. L.; Miklos, D. B.Blood
352018Nonmyeloablative Allogeneic Transplantation Using TLI-ATG Conditioning for Lymphoid and Myeloid Malignancies: Mature Follow-up from a Large, Single Institution CohortSpinner, M. A.; Kennedy, V. E.; Tamaresis, J. S.; Lavori, P. W.; Elder, L. V.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Hoppe, R. T.; Strober, S.; Lowsky, R.Blood
362018Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD)Gupta, R.; Albabtain, A.; Arai, S.; Kwong, B.; Wen-Kai Weng Blood
372018兩相流模式應用於波浪與複合式波浪形沒水結構物交互作用之數值研究石瑞祥 ; 翁文凱 ; 李基毓 第四十屆海洋工程研討會論文集
382018外壁開孔同心圓柱於波浪作用下之受力試驗翁文凱 ; 許泰源; 李基毓 第 40 屆海洋工程研討會論文集
392018不同地形下方向波譜的應用與比較:以太平島模型為例翁文凱 ; 黃俞文; 石瑞祥 ; 朱志誠; 賴彥廷第四十屆海洋工程研討會論文集
402018Experimental Study on the Generation and Attenuation of Landslide TsunamisShih, Ruey-Syan ; Weng, Wen-Kai ; Li, Chi-Yu J COASTAL RES5
412018Experimental Study on the Energy Dissipation Characteristics of Stepped EmbankmentsRuey-Syan Shih ; Wen-Kai Weng ; Chi-Yu Li The 28th International Ocean and Polar Engineering Conference
422018Experimental study on the effects of external electrical resistance on the efficiency of a point absorber wave energy converterChi-Yu Li ; Wen-Kai Weng ; Ruey-Syan Shih ; Hung-Yi Chen; Sheng-Yang WuThe 28th International Ocean and Polar Engineering Conference
432018Potential Association of Anti-CCR4 Antibody Mogamulizumab and Graft-vs-Host Disease in Patients With Mycosis Fungoides and Sezary SyndromeDai, J.; Almazan, T. H.; Hong, E. K.; Khodadoust, M. S.; Arai, S.; Wen-Kai Weng ; Kim, Y. H.Jama Dermatology
442018Phase I/II Trial for Patients with Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT with a T Cell Depleted Graft with Infusion of Conventional T Cells and Regulatory T CellsMeyer, E.; Laport, G. G.; Tantsura, I.; Tang, S. W.; Sahaf, B.; Rangarajan, K.; Armstrong, R.; Tate, K.; Tudisco, C.; Sheehan, K.; Arai, S.; Johnston, L.; Muffly, L.; Lowsky, R.; Rezvani, A.; Wen-Kai Weng ; Miklos, D.; Negrin, R. S.Biology of Blood and Marrow Transplantation
452018Infusion of donor-derived CD8(+) memory T cells for relapse following allogeneic hematopoietic cell transplantationMuffly, L.; Sheehan, K.; Armstrong, R.; Jensen, K.; Tate, K.; Rezvani, A. R.; Miklos, D.; Arai, S.; Shizuru, J.; Johnston, L.; Meyer, E.; Wen-Kai Weng ; Laport, G. G.; Negrin, R. S.; Strober, S.; Lowsky, R.Blood Advances
462018Wave Energy Dissipation by the Skirt-induced Vortices: Visualization with Hydrogen Bubble GeneratorChi-Yu Li ; Wen-Kai Weng ; Ruey-Syan Shih ; Yu-Cong WangProceeding of 9th Chinese-German Joint Symposium on Hydraulic and Ocean Engineering, Nov. 10-16
472017Consolidative CD8(+) Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell TransplantationSpinner, M. A.; Muffly, L. S.; Arai, S.; Johnston, L.; Meyer, E. H.; Miklos, D. B.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Strober, S.; Lowsky, R.Blood
482017外部負載下新型點吸收式波能轉換裝置最大發電效能之研究翁文凱 ; 陳弘彝; 李基毓 ; 石瑞祥 第三十九屆海洋工程研討會論文集
492017階梯形堤面對波浪溯上及反射率之研究石瑞祥 ; 翁文凱 ; 李基毓 ; 盧哲玄; 黃懷文第三十八屆海洋工程研討會論文集
502017可動板式潛堤波能擷取系統特性之研究翁文凱 ; 李冠勳; 李基毓 ; 石瑞祥 第 三十九屆海洋工程研討會論文集
512017新月形沒水平板對點吸收式波力發電場擷取效能提升之研究翁文凱 ; 羅正暄; 石瑞祥 ; 李基毓 第三十九屆海洋工程研討會論文集
522017振盪水柱式發電系統考慮真實氣體可壓縮特性之研究石瑞祥 ; 翁文凱 ; 李基毓 ; 劉永慶第三十九屆海洋工程研討會論文集
532017Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell TransplantationVeeraputhiran, M.; Yang, L. Y.; Sundaram, V.; Arai, S.; Lowsky, R.; Miklos, D.; Meyer, E.; Muffly, L.; Negrin, R.; Rezvani, A.; Shizuru, J.; Wen-Kai Weng ; Johnston, L.Biology of Blood and Marrow Transplantation
542017Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantationKuklinski, L. F.; Li, S. F.; Karagas, M. R.; Wen-Kai Weng ; Kwong, B. Y.Journal of the American Academy of Dermatology
552017HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activitySpinner, M. A.; Fernandez-Vina, M.; Creary, L. E.; Quinn, O.; Elder, L.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Shizuru, J. A.; Wen-Kai Weng ; Laport, G. G.; Strober, S.; Lowsky, R.; Rezvani, A. R.Blood Advances
562017Gain of CD26 expression on the malignant T-cells in relapsed erythrodermic leukemic mycosis fungoidesCedeno-Laurent, F.; Wysocka, M.; Obstfeld, A. E.; Novoa, R. A.; Vittorio, C. C.; Kim, E. J.; Wen-Kai Weng ; Rook, A. H.Journal of Cutaneous Pathology
572017Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit LymphomaChoi, T.; Kodali, M. K.; Wen-Kai Weng Biology of Blood and Marrow Transplantation
582016Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated DonorsSpinner, M. A.; Vina, M. F.; Elder, L.; Arai, S.; Johnston, L.; Meyer, E.; Miklos, D.; Muffly, L.; Negrin, R. S.; Shizuru, J.; Wen-Kai Weng ; Laport, G. G.; Strober, S.; Lowsky, R.; Rezvani, A. R.Blood
592016A Single-Arm PHASE 2A Study of NM-IL-12 (rHu-IL12) in Patients with Mycosis Fungoides-Type CTCL (MF) Undergoing Low-Dose TOTAL Skin Electron BEAM Therapy (LD-TSEBT)Kim, Y. H.; Hoppe, R. T.; Rook, A. H.; Maity, A.; Geskin, L. J.; Horowitz, D. P.; Finnegan, G.; Khodadoust, M.; Wen-Kai Weng ; Lares, A.; Hong, E. K. J.; Buchanan, M.; Ma, V.; Kha, H.; Lawrence, C. E.; Vainstein, V.; Basile, L. A.Blood
602016Phase I Study of CD8 Memory T-Cell Donor Lymphocyte Infusion for Relapse of Hematologic Malignancies Following Matched Related Donor Allogeneic Hematopoietic Cell TransplantationMuffly, L. S.; Sheehan, K.; Armstrong, R.; Tate, K.; Tudisco, C.; Rezvani, A. R.; Miklos, D.; Arai, S.; Shizuru, J.; Johnston, L.; Meyer, E.; Wen-Kai Weng ; Laport, G. G.; Negrin, R. S.; Strober, S.; Lowsky, R.Blood
612016Risk of Non-Melanoma Skin Cancer Following Hematopoietic Cell Transplantation and Voriconazole-Associated RiskKuklinski, L. F.; Li, S. F.; Karagas, M. R.; Kwong, B. Y.; Wen-Kai Weng Blood
622016固定點吸收式波力發電系統之研究翁文凱 ; 李基毓 ; 陳楓霖; 陳弘彝第 38 屆海洋工程研討會暨科技部計畫成果發表會 論文集
632016Experimental Study on the Characteristic of Tsunami Generation by Slumps and LandslidesRuey-Syan Shih ; Wen-Kai Weng Proceeding of 8th Chinese-German Joint Symposium on Hydraulic and Ocean Engineering
642016Study on the Energy Conversion Efficiency Enhancement of a Fixed Point Absorption Wave ConverterChi-Yu Li ; Fong-Lin Chen; Wen-Kai Weng 
652016Validation of the hematopoietic cell transplantation-specific comorbidity index in non-myeloablative allogeneic stem cell transplantationVeeraputhiran, M.; Arai, S.; Lowsky, R.; Miklos, D. B.; Meyer, E.; Muffly, L. S.; Negrin, R.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Johnston, L. J.Journal of Clinical Oncology
662016Long-term outcomes of high-dose melphalan and carmustine followed by autologous hematopoietic cell transplantation for multiple myelomaNeppalli, A. K.; Shizuru, J.; Johnston, L. J.; Muffly, L. S.; Wen-Kai Weng ; Negrin, R.; Meyer, E.; Laport, G.; Lowsky, R.; Arai, S.; Miklos, D. B.; Rezvani, A. R.Journal of Clinical Oncology
672016Long-Term Outcomes of AML Patients Using Total Lymphoid Irradiation with Anti-Thymocyte GlobulinNakasone, H.; Miklos, D. B.; Meyer, E.; Rezvani, A.; Muffly, L.; Wen-Kai Weng ; Arai, S.; Johnston, L.; Laport, G. G.; Shizuru, J. A.; Negrin, R.; Strober, S.; Lowsky, R.Biology of Blood and Marrow Transplantation
682016Experimental determination of the performance characteristics of an undulating submerged obstacleShih, Ruey-Syan ; Weng, Wen-Kai SHIPS OFFSHORE STRUC7
692016Dynamic Behaviors of a Moored Floating Structure with Flexible SkirtsWen-Kai Weng ; Duc-Tru Tran; Ruey-Syan Shih Journal of Energy and Power Engineering0
702016A Study of Long Wave Attenuation over Composite Undulating BreakwatersShih, Ruey-Syan ; Weng, Wen-Kai J COASTAL RES5
712016翼板結構物引起之渦流的消能特性研究翁文凱 ; 王昱璁; 石瑞祥 ; 李基毓 第三十八屆海洋工程研討會論文集
722016新月型沒水平板附近波場特性之分析研究翁文凱 ; 楊嘉凱; 石瑞祥 ; 李基毓 第三十八屆海洋工程研討會論文集
732015Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim AnalysisChu, M. P.; Brody, J.; Kohrt, H. E.; Frank, M. J.; Khodadoust, M.; Reddy, S.; Advani, R. H.; Gupta, N. K.; Laport, G.; Maeda, L. S.; Meyer, E.; Miklos, D. B.; Negrin, R.; Rezvani, A. R.; Wen-Kai Weng ; Sheehan, K.; Faham, M.; Czerwinski, D. K.; Okada, A.; Levy, R.Blood
742015Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid NeoplasmsNarayan, R.; Benjamin, J.; Laport, G.; Tian, L.; Tate, K.; Elder, L.; Galvez, L.; Armstrong, R.; Sheehan, K.; Lowsky, R.; Arai, S.; Johnston, L.; Miklos, D.; Muffly, L. S.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Strober, S.; Negrin, R.; Meyer, E.Blood
752015Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative ProjectKim, Y. H.; Tavallaee, M.; Sundram, U.; Salva, K. A.; Wood, G. S.; Li, S. F.; Rozati, S.; Nagpal, S.; Krathen, M.; Reddy, S.; Hoppe, R. T.; Nguyen-Lin, A.; Wen-Kai Weng ; Armstrong, R.; Pulitzer, M.; Advani, R. H.; Horwitz, S. M.Journal of Clinical Oncology
762015Analysis of the Dynamics of a Floating body with Thin Skirts by Using the Dual Boundary Element MethodWen-Kai Weng ; Ruey-Syan Shih ; Duc-Tru Tran Journal of Marine Science and Technology0
772015Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioningRezvani, A. R.; Kanate, A. S.; Efron, B.; Chhabra, S.; Kohrt, H. E.; Shizuru, J. A.; Laport, G. G.; Miklos, D. B.; Benjamin, J. E.; Johnston, L. J.; Arai, S.; Wen-Kai Weng ; Negrin, R. S.; Strober, S.; Lowsky, R.Bone Marrow Transplantation
782015Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2Ungewickell, A.; Bhaduri, A.; Rios, E.; Reuter, J.; Lee, C. S.; Mah, A.; Zehnder, A.; Ohgami, R.; Kulkarni, S.; Armstrong, R.; Wen-Kai Weng ; Gratzinger, D.; Tavallaee, M.; Rook, A.; Snyder, M.; Kim, Y.; Khavari, P. A.Nature Genetics
792015Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profilePercival, M. E. M.; Medeiros, B. C.; Tian, L.; Robeson, S.; Laport, G. G.; Johnston, L. J.; Shizuru, J. A.; Miklos, D. B.; Arai, S.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R.Bone Marrow Transplantation
802015Experimental Study of Wave Impact Forces on Pervious Pipe BreakwatersRuey-Syan Shih ; Wen-Kai Weng ; Chung-Ren ChouThe 25th International Ocean and Polar Engineering Conference
812015A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemiaStrati, P.; Tong, W. G.; Vitale, C.; Wierda, W. G.; O'Brien, S.; Brown, J. R.; Wen-Kai Weng ; Kipps, T.; Keating, M. J.; Ferrajoli, A.Leukemia & Lymphoma
822015The performance characteristics of inclined highly pervious pipe breakwatersRuey-Syan Shih ; Wen-Kai Weng ; Chung-Ren Chou Ocean Engineering12
832015Numerical study of the characteristics of wave-wave interactions in a multiphase wave fieldRuey-Syan Shih ; Wen-Kai Weng Engineering Analysis with Boundary Elements1
842014Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sezary Syndrome (SS)Wen-Kai Weng ; Armstrong, R.; Arai, S.; Johnston, L.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Benjamin, J. E.; Negrin, R. S.; Reddy, S.; Million, L.; Hoppe, R. T.; Kim, Y. H.Blood
852014Use of High-Throughput Sequencing (HTS) of TCR beta to Determine the Kinetics of Graft-Versus-Lymphoma (GVL) Effect and T-Cell Repertoire Profiles after Allogeneic TransplantWen-Kai Weng ; Armstrong, R.; Arai, S.; Hoppe, R. T.; Meyer, E. H.; Kim, Y. H.Blood
862014Wave attenuation properties of composite undulating submerged breakwatersRuey-Syan Shih ; Wen-Kai Weng ; Chung-Ren ChouThe 24th International Ocean and Polar Engineering Conference
872014Total Lymphoid Irradiation-Antithymocyte Globulin Conditioning and Allogeneic Transplantation for Patients with Myelodysplastic Syndromes and Myeloproliferative NeoplasmsBenjamin, J.; Chhabra, S.; Kohrt, H. E.; Lavori, P.; Laport, G. G.; Arai, S.; Johnston, L.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R.Biology of Blood and Marrow Transplantation
882014RETRACTED: Targeting CD137 enhances the efficacy of cetuximab (Retracted article. See vol. 129, pg. 2595, 2019)Kohrt, H. E.; Colevas, A. D.; Houot, R.; Weiskopf, K.; Goldstein, M. J.; Lund, P.; Mueller, A.; Sagiv-Barfi, I.; Marabelle, A.; Lira, R.; Troutner, E.; Richards, L.; Rajapaska, A.; Hebb, J.; Chester, C.; Waller, E.; Ostashko, A.; Wen-Kai Weng ; Chen, L. P.; Czerwinski, D.; Fu, Y. X.; Sunwoo, J.; Levy, R.Journal of Clinical Investigation
892014European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantationMedeiros, B. C.; Tian, L.; Robenson, S.; Laport, G. G.; Johnston, L. J.; Shizuru, J. A.; Miklos, D. B.; Arai, S.; Benjamin, J. E.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R.Blood Cancer Journal
902014The utility of HTS TCR analyses in the management of patients with T-cell malignanciesKirsch, I. L.; Sherwood, A.; Williamson, D.; Wen-Kai Weng ; Clark, R.; Kupper, T. S.; Wu, D.; Robins, H.Journal of Clinical Oncology
912014Outcome of Tandem Autologous/Allogeneic Hematopoietic Cell Transplantation in High-Risk Non Hodgkin's Lymphoma Patients: Stanford University ExperienceWudhikarn, K.; Lavori, P.; Arai, S.; Johnston, L.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Hoppe, R. T.; Benjamin, J.; Meyer, E.; Negrin, R.; Wen-Kai Weng Biology of Blood and Marrow Transplantation
922013Minimal Residual Disease Monitoring with High-Throughput Sequencing of T Cell Receptors in Cutaneous T Cell LymphomaWen-Kai Weng ; Armstrong, R.; Arai, S.; Desmarais, C.; Hoppe, R.; Kim, Y. H.Science Translational Medicine
932013Early Infusion Of Donor-Derived CIK Cells As Consolidative Immunotherapy Following Non-Myeloablative Allogeneic Transplantation: Safety and FeasibilityBenjamin, J.; Laport, G. G.; Tate, K.; Galvez, L.; Armstrong, R.; Sheehan, K.; Arai, S.; Lowsky, R.; Johnston, L.; Miklos, D. B.; Shizuru, J.; Wen-Kai Weng ; Negrin, R.Blood
942013Developing serpent-type wave generators to create solitary wave simulations with BEMWen-Kai Weng ; Ruey-Syan Shih ; Chung-Ren Chou China Ocean Engineering0
952013Cancer Vaccines and T Cell Therapy (vol 19, pg S97, 2013)Rezvani, K.; Brody, J. D.; Kohrt, H. E.; Logan, A. C.; Advani, R.; Czerwinski, D. K.; Wen-Kai Weng ; Negrin, R. S.; Carlton, V.; Faham, M.; Levy, R.; Barrett, J.Biology of Blood and Marrow Transplantation
962013Targeting CD137 to enhance the antitumor efficacy of cetuximab by stimulation of innate and adaptive immunityKohrt, H. E.; Houot, R.; Weiskopf, K.; Goldstein, M.; Lund, P.; Lira, R. R.; Troutner, E.; Richards, L.; Rajapaksa, A.; Ostashko, A.; Wen-Kai Weng ; Chen, L. P.; Colevas, C. A. D.; Sunwoo, J.; Levy, R.Journal of Clinical Oncology
972013AN EXPERIMENTAL STUDY OF REGULAR LONG CRESTED WAVES OVER A CRESCENT TYPE SHOALJaw-Guei Lin ; Hsiao, C. S.; Wen-Kai Weng Journal of Marine Science and Technology-Taiwan
982013Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous TransplantationKanate, A. S.; Efron, B.; Chhabra, S.; Kohrt, H.; Shizuru, J. A.; Laport, G. G.; Miklos, D. B.; Benjamin, J.; Johnston, L.; Arai, S.; Wen-Kai Weng ; Negrin, R.; Strober, S.; Lowsky, R.Biology of Blood and Marrow Transplantation
992013TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPNBenjamin, J.; Chhabra, S.; Kohrt, H.; Laport, G. G.; Arai, S.; Johnston, L.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Negrin, R.; Lowsky, R.Biology of Blood and Marrow Transplantation
1002013Cancer Vaccines and T Cell TherapyRezvani, K.; Brody, J. D.; Kohrt, H. E.; Logan, A. C.; Advani, R.; Czerwinski, D. K.; Wen-Kai Weng ; Negrin, R. S.; Carlton, V.; Faham, M.; Levy, R.; Barrett, J.Biology of Blood and Marrow Transplantation
1012013Numerical Modeling of Wave Field Around Multiple Submerged BreakwatersRuey-Syan Shih ; Wen-Kai Weng ; Chung Ren ChouMarine Science0
1022013Experimental Determination on the Performance Characteristics of Undulating Submerged Obstacle: Comparison Between Regular and Irregular Wave ResponseRuey-Syan Shih ; Wen-Kai Weng ; Chou Chung-renThe 23rd International Offshore and Polar Engineering Conference
1032012Non-Myeloablative Conditioning with Total Lymphoid Irradiation and ATG and Allogeneic Transplantation for Patients with Myelodysplastic Syndrome, Therapy-Related Myeloid Neoplasms, and Myeloproliferative NeoplasmsBenjamin, J.; Chhabra, S.; Kohrt, H. E.; Laport, G. G.; Arai, S.; Johnston, L.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R.Blood
1042012Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcriptsLee, C. S.; Ungewickell, A.; Bhaduri, A.; Qu, K.; Webster, D. E.; Armstrong, R.; Wen-Kai Weng ; Aros, C. J.; Mah, A.; Chen, R. O.; Lin, M. H.; Sundram, U.; Chang, H. Y.; Kretz, M.; Kim, Y. H.; Khavari, P. A.Blood
1052012Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidenceArai, S.; Sahaf, B.; Narasimhan, B.; Chen, G. L.; Jones, C. D.; Lowsky, R.; Shizuru, J. A.; Johnston, L. J.; Laport, G. G.; Wen-Kai Weng ; Benjamin, J. E.; Schaenman, J.; Brown, J.; Ramirez, J.; Zehnder, J. L.; Negrin, R. S.; Miklos, D. B.Blood
1062012Graft-versus-lymphoma effect after non-myeloablative allogeneic transplant induces molecular remission assessed by high-throughput sequencing of T cell receptor in patients with advanced stage mycosis fungoides (MF) and Sezary syndrome (SS)Wen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H.Journal of Investigative Dermatology
1072012Effect of stimulation of natural killer cells with an anti-CD137 mAb on the efficacy of trastuzumab, cetuximab, and rituximabKohrt, H. E.; Houot, R.; Weiskopf, K.; Goldstein, M.; Lund, P.; Scheeren, F.; Czerwinski, D.; Colevas, A. D.; Wen-Kai Weng ; Clarke, M. F.; Carlson, R. W.; Sunwoo, J.; Tedder, T.; Chen, L. P.; Levy, R.Journal of Clinical Oncology
1082012Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myelomaChen, A. I.; Negrin, R. S.; McMillan, A.; Shizuru, J. A.; Johnston, L. J.; Lowsky, R.; Miklos, D. B.; Arai, S.; Wen-Kai Weng ; Laport, G. G.; Stockerl-Goldstein, K.Bone Marrow Transplantation
1092012The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patientsKelly-Sell, M. J.; Kim, Y. H.; Straus, S.; Benoit, B.; Harrison, C.; Sutherland, K.; Armstrong, R.; Wen-Kai Weng ; Showe, L. C.; Wysocka, M.; Rook, A. H.American Journal of Hematology
1102012RETRACTED: Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer (Retracted article. See vol. 129, pg. 2595, 2019)Kohrt, H. E.; Houot, R.; Weiskopf, K.; Goldstein, M. J.; Scheeren, F.; Czerwinski, D.; Colevas, A. D.; Wen-Kai Weng ; Clarke, M. F.; Carlson, R. W.; Stockdale, F. E.; Mollick, J. A.; Chen, L. P.; Levy, R.Journal of Clinical Investigation
1112011CCD 遙測波浪適用於現場觀測研究(II)周宗仁; 石瑞祥 ; 翁文凱 ; 黃恩得第三十三屆海洋工程研討會論文集
1122011Graft-Versus-Lymphoma Effect After Non-Myeloablative Allogeneic Transplant Induces Molecular Remission Assessed by High-Throughput Sequencing of T Cell Receptor in Patients with Advanced Stage Mycosis Fungoides and Sezary SyndromeWen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H.Blood
1132011Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell TransplantationLaport, G. G.; Sheehan, K.; Baker, J.; Armstrong, R.; Wong, R. M.; Lowsky, R.; Johnston, L. J.; Shizuru, J. A.; Miklos, D.; Arai, S.; Benjamin, J. E.; Wen-Kai Weng ; Negrin, R. S.Biology of Blood and Marrow Transplantation
1142011Immunotransplant for Mantle Cell Lymphoma: Phase I/II Study Preliminary ResultsBrody, J. D.; Czerwinski, D. K.; Carlton, V.; Moorhead, M.; Zheng, J. B. A.; Klinger, M.; Faham, M.; Advani, R.; Kohrt, H. E.; Alizadeh, A. A.; Negrin, R. S.; Weng, WK ; Sheehan, K.; Levy, R.Blood0
1152011A prospective trial of low-dose total skin electron beam therapy in mycosis fungoides and proposal of a new clinically meaningful endpointBashey, S.; Harrison, C.; Navi, D.; Lingala, B.; Armstrong, R.; Wen-Kai Weng ; Sundram, U.; Kim, Y. H.; Hoppe, R.Journal Der Deutschen Dermatologischen Gesellschaft
1162011Experimental investigation on the effect of tensile pre-strain on ratcheting behavior of 430 Stainless Steel under fully-reversed loading conditionChiou, Y. C.; Wen-Kai Weng ; Yi-Ming Jen Engineering Failure Analysis
1172010CCD 遙測波浪適用於現場觀測研究(量測區域正射化處理)石瑞祥 ; 翁文凱 ; 官昭純; 周宗仁第三十二屆海洋工程研討會論文集
1182010CCD遙測波浪適用於現場觀測研究(室內實驗水槽量測)翁文凱 ; 周宗仁; 石瑞祥 ; 黃恩淂第三十二屆海洋工程研討會論文集
1192010Phase I/II Trial of GN-BVC, a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin LymphomaArai, S.; Letsinger, R.; Wong, R. M.; Johnston, L. J.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Lavori, P. W.; Blume, K. G.; Negrin, R. S.; Horning, S. J.Biology of Blood and Marrow Transplantation
1202010Application of restoring force theory to increasing wave power generation under weak fluctuationsRuey-Syan Shih ; Wen-Kai Weng ; Chung-ren ChouThe 20th International Offshore and Polar Engineering Conference
1212010Immunoglobulin G Fc Receptor Fc gamma RIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's LymphomaWen-Kai Weng ; Negrin, R. S.; Lavori, P.; Horning, S. J.Journal of Clinical Oncology
1222009A Dose Escalation Trial of Imatinib for Steroid Dependent Chronic Graft-Versus-Host Disease with Anti-PDGFRA Antibody AnalysisChen, G. L.; Arai, S.; Flowers, M. E. D.; Otani, J.; Cheng, E. C.; McMillan, A.; Wen-Kai Weng ; Shizuru, J.; Johnston, L.; Miklos, D.Blood
1232009TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donorsKohrt, H. E.; Turnbull, B. B.; Heydari, K.; Shizuru, J. A.; Laport, G. G.; Miklos, D. B.; Johnston, L. J.; Arai, S.; Wen-Kai Weng ; Hoppe, R. T.; Lavori, P. W.; Blume, K. G.; Negrin, R. S.; Strober, S.; Lowsky, R.Blood
1242009Numerical Modelling of 3D Oblique Waves by L-type Multiple Directional Wave GeneratorRuey-Syan Shih ; Chung-ren Chou; Wen-Kai Weng Proceedings of the Nineteenth (2009) International Offshore and Polar Engineering Conference
1252009Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphomaTimmerman, J. M.; Vose, J. M.; Czerwinski, D. K.; Wen-Kai Weng ; Ingolia, D.; Mayo, M.; Denney, D. W.; Levy, R.Leukemia & Lymphoma
1262009Genetic polymorphism of the inhibitory IgG Fc receptor FcRIIb is not associated with clinical outcome in patients with follicular lymphoma treated with rituximabWen-Kai Weng ; Levy, R.Leukemia & Lymphoma
1272009Immunoglobulin G Fc receptor polymorphisms do not correlate with response to chemotherapy or clinical course in patients with follicular lymphomaWen-Kai Weng ; Levy, R.Leukemia & Lymphoma
1282008Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Non-Myeloablative Conditioning with Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Confirm a Low Incidence of Graft Versus Host Disease (GVHD) with Retained Anti-Tumor ActivityKohrt, H.; Turnbull, B.; Laport, G.; Miklos, D.; Shizuru, J.; Johnston, L.; Arai, S.; Wen-Kai Weng ; Benjamin, J.; Blume, K.; Negrin, R.; Lavori, P.; Strober, S.; Lowsky, R.Blood
1292008Phase I/II Trial of a Novel Gemcitabine and Vinorelbine-Containing Conditioning Regimen in Autologous Hemotopoietic Cell Transplantation for High-Risk Recurrent and Refractory Hodgkin LymphomaArai, S.; Letsinger, R.; Johnston, L.; Laport, G.; Lowsky, R.; Miklos, D.; Shizuru, J.; Wen-Kai Weng ; Wong, R.; Lavori, P.; Blume, K.; Negrin, R.; Horning, S.Blood
1302008Prophylactic Rituximab after Reduced Intensity Conditioning Transplantation Results in Low Chronic GvhdArai, S.; Sahaf, B.; Jones, C.; Zhender, J.; Lowsky, R.; Strober, S.; Shizuru, J.; Negrin, R.; Johnston, L.; Laport, G.; Schaenman, J.; Brown, J.; Wen-Kai Weng ; Letsinger, R.; Wong, R.; Lavori, P.; Miklos, D.Blood
1312008A Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following Rituximab Therapy of Follicular LymphomaRacila, E.; Link, B. K.; Wen-Kai Weng ; Witzig, T. E.; Ansell, S.; Maurer, M. J.; Huang, J.; Dahle, C.; Halwani, A.; Levy, R.; Weiner, G. J.Clinical Cancer Research
1322008The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cellsLuqman, M.; Klabunde, S.; Lin, K.; Georgakis, G. V.; Cherukuri, A.; Holash, J.; Goldbeck, C.; Xu, X. M.; Kadel, E. E.; Lee, S. H.; Aukerman, S. L.; Jallal, B.; Aziz, N.; Wen-Kai Weng ; Wierda, W.; O'Brien, S.; Younes, A.Blood
1332008A three-point method for estimating wave reflection of obliquely incident waves over a sloping bottomWang, S. K.; Tai-Wen Hsu ; Ou, S. H.; Wen-Kai Weng Coastal Engineering
1342007Autologous cytokine-induced killer cells as post-transplant cellular immunotherapyArai, S.; Sheehan, K.; Moore, S.; Laport, G.; Johnston, L.; Lowsky, R.; Miklos, D.; Goldstein, K.; Wen-Kai Weng ; Shizuru, J.; Horning, S.; Negrin, R.Blood
1352007The prediction of the dynamic and structural motions of a floating-pier system in wavesLee, H. H.; Chen, L. Y.; Wen-Kai Weng ; Shyue, S. W.Ocean Engineering
1362007Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphorna patients regardless of their response to induction chemotherapyWen-Kai Weng ; Czerwinski, D.; Levy, R.Blood
1372007Analysis of responses of floating dual pontoon structureWen-Kai Weng ; Chou, C. R.China Ocean Engineering
1382006The long term clinical outcome of B cell lymphoma patients treated with anti-idiotype monoclonal antibody correlated with the isotype of the therapeutic antibodyWen-Kai Weng ; Czerwinski, D.; Levy, R.Blood
1392006三維數值水槽之開發與研究(III)周宗仁; 石瑞祥 ; 翁文凱 第二十八屆海洋工程研討會論文集
1402006Wave setup and setdown generated by obliquely incident wavesTai-Wen Hsu ; Hsu, J. R. C.; Wang, S. K.; Ou, S. H.; Wen-Kai Weng Coastal Engineering
1412005A non-internalizing anti-CD40 antibody, CHIR-12.12, blocks CD40L-induced cytokine production and mediates greater ADCC than rituximab in primary CLL cellsTong, X.; Aukerman, S. L.; Lin, K.; Aziz, N.; Goldbeck, C.; Georgakis, G. V.; Younes, G.; Wen-Kai Weng ; O'Brien, S.; Wierda, W.; Jallal, B.; Luqman, M.Blood
1422005A polymorphism in the C1qA component of complement correlates with prolonged complete remission following rituximab therapy of follicular lymphomaRacila, E.; Wen-Kai Weng ; Wooldridge, J. E.; Link, B. K.; Levy, R.; Weiner, G. J.Blood
1432005Rituximab variants with re-engineered Fc with higher affinity to activating Fc gamma R eliminate the functional difference between Fc gamma R genotypesWen-Kai Weng ; Stavenhagen, J.; Koenig, S.; Levy, R.Blood
1442005Genetic polymorphism of the inhibitory IgG Fc receptor Fc gamma RIIb is not associated with clinical outcome of rituximab treated follicular lymphoma patientsWen-Kai Weng ; Levy, R.Blood
1452005Enhancing the performance of organic light-emitting devices by selective thermal treatmentSun, M. C.; Jou, J. H.; Wen-Kai Weng ; Huang, Y. S.Thin Solid Films
1462005Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapyWen-Kai Weng ; Czerwinski, D.; Levy, R.Blood
1472005Use of dendritic cells and GM-CSF adjuvant are associated with anti-idiotype cellular immune response following idiotype vaccination in follicular lymphoma patientsWen-Kai Weng ; Czerwinski, D.; Levy, R.Blood
1482004Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotypeWen-Kai Weng ; Czerwinski, D.; Timmerman, J.; Hsu, F. J.; Levy, R.Journal of Clinical Oncology
1492004A fully human anti-CD40 antagonistic antibody, CHIR-12.12, inhibit the proliferation of human B cell non-Hodgkin's lymphomaWen-Kai Weng ; Tong, X.Blood
1502004Immunoglobulin G Fc receptor polymorphisms and clinical course in follicular lymphoma patientsWen-Kai Weng ; Rosenberg, A.; Levy, R.Blood
1512004Fc-gamma R IIIa polymorphism and anti-idiotype humoral immune response predict clinical outcome in follicular lymphoma patients receiving idiotypic vaccinationWen-Kai Weng ; Czerwinski, D.; Levy, R.Journal of Clinical Oncology
1522003Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphomaWen-Kai Weng ; Levy, R.Journal of Clinical Oncology
1532003Analysis of tumor-specific T cell immune response in follicular non-Hodgkin's lymphoma patients treated with rituximabWen-Kai Weng ; Levy, R.Blood
1542003Hepatitis C virus (HCV) and lymphomagenesisWen-Kai Weng ; Levy, S.Leukemia & Lymphoma
1552002Analysis of IgG Fc receptor Fc gamma RIIIa polymorphism in relapsed follicular non-Hodgkin's lymphoma patients treated with RituximabWen-Kai Weng ; Levy, R.Blood
1562002Rituximab-induced antibody-dependent cellular cytotoxicity (ADCC) in follicular non-Hodgkin's lymphomaWen-Kai Weng ; Levy, R.Blood
1572002High-efficiency white organic light-emitting devices with dual doped structureHuang, Y. S.; Jou, J. H.; Wen-Kai Weng ; Liu, J. M.Applied Physics Letters
1582001Rituximab-induced Annexin-V staining of tumor cells does not predict clinical outcome following Rituximab treatment in follicular non-Hodgkin's lymphomaWen-Kai Weng ; Levy, R.Blood
1592001Human anti-CD40 antagonistic antibodies, inhibit the proliferation of human B cell non-Hodgkin's lymphomaWen-Kai Weng ; Wang, C. Y.; Chu, K. T.; Levy, R.Blood
1602001Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphomaWen-Kai Weng ; Levy, R.Blood
1612001Studies on modifications of ITO surfaces in OLED devices by Taguchi methodsLiu, J. M.; Lu, P. Y.; Wen-Kai Weng Materials Science and Engineering B-Solid State Materials for Advanced Technology
1621997Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cellsWen-Kai Weng ; Shah, N.; O'Brien, D.; Van Ness, B.; LeBien, T. W.Journal of Immunology
1631995SIGNALING THROUGH CD19 ACTIVATES AP1 TRANSCRIPTION FACTORS IN HUMAN B-LINEAGE CELLSWen-Kai Weng ; Obrien, D.; Vanness, B.; Lebien, T. W.Faseb Journal
164-Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myelomaLemieux, C.; Muffly, L. S.; Rezvani, A.; Lowsky, R.; Iberri, D. J.; Craig, J. K.; Frank, M. J.; Johnston, L. J.; Liedtke, M.; Negrin, R.; Wen-Kai Weng ; Meyer, E.; Shizuru, J.; Shiraz, P.; Arai, S.; Miklos, D. B.; Sidana, S.Bone Marrow Transplantation